Skip to content

Clear monthly pricing. Clinical consultation and standard shipping included.

Fictional demonstration website.

ClientRx
Tirzepatide5 mg/mLInjectable solutionRX ONLY

Product. Product imagery is an illustrative demonstration mock-up; labels, lots, and concentrations shown are not real.

Weight Management

Tirzepatide Program

A clinician-guided weight-management program using tirzepatide, with provider review and one clear monthly price.

$249/month

All-inclusive program price · Illustrative demonstration pricing

  • Online licensed-provider review
  • Secure medical intake after checkout
  • Ongoing program support by secure message
  • Standard shipping
  • Routine follow-up required by the program

May be compounded — not FDA-approved

5 mg/mL (illustrative demonstration concentration)

Available in eligible states, subject to pharmacy and regulatory review.

Purchasing a program does not guarantee that a prescription will be issued. If the provider does not approve treatment, the order will be handled according to the ClientRx refund and cancellation policy. Laboratory testing, expedited shipping, replacement products, and third-party services are not included unless specifically stated.

Demonstration notice. ClientRx is a fictional demonstration telehealth brand. Products, pricing, providers, pharmacies, and testimonials shown are illustrative only.

About this program

The ClientRx Tirzepatide Program is a clinician-guided weight-management program. As with every ClientRx program, purchase comes first, the secure medical intake follows, and a licensed clinician determines whether treatment is appropriate.

Tirzepatide is a dual GIP and GLP-1 receptor agonist. The FDA has approved branded tirzepatide products for specific indications. Those approved branded products are distinct from any compounded tirzepatide formulation, and ClientRx does not describe a compounded formulation as Zepbound or Mounjaro.

This program is generally considered for adults with weight-related health goals who can be managed safely at a distance. Clinicians may request laboratory work or additional history, and may decline to treat.

Program support continues after approval. Follow-up is part of the monthly price, and your clinician may adjust or discontinue a program at any point based on how you respond.

How it may work

Tirzepatide acts on two incretin pathways rather than one. In general educational terms, those pathways are involved in appetite regulation, insulin response, and gastric emptying.

Whether a dual-pathway product suits you better than a single-pathway one is a clinical judgment, not a purchase decision. Some people tolerate one and not the other.

This page contains no dosing schedule and no self-administration instructions. Those come only from the prescribing clinician and dispensing pharmacy where a program is approved.

Safety summary

  • Gastrointestinal effects are the most commonly described: nausea, vomiting, diarrhoea, constipation, reduced appetite, and abdominal pain.
  • Serious risks described for this class include pancreatitis, gallbladder disease, dehydration-related kidney injury, and hypoglycaemia in combination with certain diabetes medicines.
  • This summary is high level. Seek immediate care for severe or persistent abdominal pain, ongoing vomiting, or allergic symptoms.

This summary is not a complete list of risks and is not medical advice. Visit the safety center. In an emergency, call 911.

Program questions

No. Those are FDA-approved branded tirzepatide products. This demonstration program is described separately and may involve a compounded formulation, which is a different product.

Related programs

Longevity and Wellness

NAD+

A provider-directed wellness program framed around cellular-energy support, with deliberately cautious claims.

$199/month

All-inclusive program price · Illustrative demonstration pricing

View Program